Long non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer
Q. You, H.-Y. Shi, C.-F. Gong, X.-Y. Tian, S. Li Department of Gynecology and Obstetrics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Long non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer, by Q. You, H.-Y. Shi, C.-F. Gong, X.-Y. Tian, S. Li, published in Eur Rev Med Pharmacol Sci 2019;23 (15): 6429-6435–DOI: 10.26355/eurrev_201908_18524–PMID: 31378881” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadLong non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
Q. You, H.-Y. Shi, C.-F. Gong, X.-Y. Tian, S. Li
Long non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 16
Pages: 8243-8243
DOI: 10.26355/eurrev_202001_22583